Metabolic effects of cancer

British Journal of Surgery

Volumn 77, Issue 3, 1990, Pages 246-254

  Douglas, R G ^a   Shaw, J H F ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

cachexia; Cancer; fat; glucose; metabolism; parenteral nutrition; protein

Indexed keywords

FAT; GLUCOSE; RADIOISOTOPE;

CACHEXIA; ENERGY; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

CACHEXIA; ENERGY METABOLISM; GLUCONEOGENESIS; GLUCOSE; HUMAN; LIPIDS; NEOPLASMS; PARENTERAL NUTRITION, TOTAL; PROTEINS;

EID: 0025276471     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800770305     Document Type: Review

References (148)

1. The immediate cause of death in cancer
2. Nutritional support in cancer
3. Serum albumin and body weight as predictors of postoperative course in colorectal cancer
4. Mortality and morbidity after esophagogastrectomy for cancer of the esophagus and cardia
5. Uncomplicated starvation versus cancer cachexia
6. Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion, parenteral feeding, and surgical resection
7. Fatty acids and glycerol kinetics in septic patients and in patients with gastrointestinal cancer: the response to glucose infusion and parenteral feeding
8. Cancer cachexia
9. Role of parenteral hyperalimentation in management of multiple catastrophic complications
10. Changes in body composition in patients with small‐cell lung cancer: the effect of total parenteral nutrition as an adjunct to chemotherapy
11. Glucose metabolism in cachectic cancer patients with colorectal cancer
12. Animal models for the study of cancer‐induced anorexia
13. Excessive caloric expenditure as a cause of malnutrition in patients with cancer
14. Resting energy expenditure in controls and cancer patients with localized and diffuse disease
15. Whole body lipid and energy metabolism in the cancer patient
16. The effect of gastrointestinal malignancy on resting metabolic expenditure
17. Does increasing resting energy expenditure cause cancer cachexia?
18. Energy balance and body composition in cancer patients
19. The relationship between resting energy expenditure and weight loss in benign and malignant disease
20. Influences of whole body protein turnover rate on resting energy expenditure in patients with cancer
21. Energy expenditure and gynecological cancer
22. Energy and protein metabolism in sarcoma patients
23. Metabolism in hematologic malignancy
24. Energy expenditure in relation to caloric intake in patients with lung carcinoma
25. Energy expenditure in malnourished gastrointestinal cancer patients
26. Factors affecting energy output
27. Changes of basal metabolic rate in man in semistarvation and refeeding
28. Cancer cachexia
29. Pathogenesis of cachexia in cancer: a review and a hypothesis
30. Cancer cachexia
31. Lactate metabolism in patients with cancer
32. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients
33. Medical abnormalities in the cancer patient
34. Energy and protein metabolism in sepsis and trauma
35. Glucose turnover and recycling in colorectal carcinoma
36. Metabolic abnormalities in cancer patients: carbohydrate metabolism
37. Altered glucose metabolism in metastatic carcinoma
38. Carbohydrate metabolism in cancer cachexia
39. Carbohydrate metabolism in normal man and effect of glucose infusion
40. Lactic acidosis in malignancy and observations on its possible pathogenesis
41. Gluconeogenesis from alanine in patients with progressive malignant disease
42. Nutritional support of the patient with esophageal cancer
43. Enzymes of gluconeogenesis in tumour‐bearing rats
44. Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers and hepatoma cell cultures
45. Mammalian carbohydrate metabolism
46. Metabolic alterations in a non‐cachectic animal tumour system
47. Quantitative estimation of the Cori cycle in man
48. Lactate metabolism in metastatic colo‐rectal cancer
49. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding
50. Peripheral tissue metabolism in cancer‐bearing man
51. Tumour glycolysis‐host gluconeogenesis in cancer cachexia
52. Energy metabolism and requirements in the cancer patient
53. The glucose metabolism of patients with malignant disease and normal subjects as studied by means of an intravenous glucose tolerance test
54. Metabolic approaches to cancer cachexia
55. Cachexia of malignancy: potential role of insulin in nutritional management
56. Mechanism of impaired glucose tolerance in patients with neoplasia
57. Insulin resistance in patients with cancer
58. Supportive care of the cancer patient
59. In vivo utilization of substrate by human sarcoma‐bearing limbs
60. Hypoglycaemia associated with non‐islet cell tumor and insulin‐like growth factors: a study of tumor types
61. The riddle of tumor hypoglycemia revisited
62. Metabolic response to total parenteral nutrition in cancer patients
63. A comparative study of the influence of malignant tumour on host metabolism in mice and man
64. Contribution of fat loss to weight loss in cancer
65. Cachexia, the metabolic component of metastatic disease
66. Body composition and dietary intake in neoplastic disease
67. Body compositional changes in cancer patients
68. Anorexia and weight loss in cancer patients
69. Fatty acid mobilization in cancer patients
70. Peculiarities of hyperlipidaemia in tumour patients
71. Reduced plasma lipoprotein lipase activity in patients with malignancy associated weight loss
72. Oxidation and metabolic interconversion in malignant cachexia
73. 2
74. Carbohydrate metabolism in subjects with cancer
75. Depression of the total body respiratory quotient in human malignant disease
76. Abnormalities in glucose and protein metabolism in non‐cachectic lung cancer patients
77. Increased whole‐body prolein lurnover in sick children with newly diagnosed leukaemia or lymphoma
78. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphatic leukaemia
79. Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer
80. Effect of cytotoxic agents on protein kinetics in patients with metastatic cancer
81. Whole‐body tyrosine flux in relation to energy expendilure in weighl‐losing cancer palients
82. Whole body protein lurnover, synthesis and breakdown in patients with colorectal carcinoma
83. Deranged tissue metabolism as the basis of cancer cachexia
84. Whole body protein kinetics during acute starvation and intravenous refeeding in normal man
85. Cancer cachexia and protein metabolism
86. Leucine metabolism in patients with malignant disease
87. Metabolic basis of energy expenditure with particular reference to protein
88. Nutrition and protein turnover in man
89. Nitrogen metabolism in cancer patients
90. DNA synthesis in rat sarcoma and liver: Ihe effecl of slarvation
91. Effect of chronic protein malnutrition on host‐lumour composilion and growth
92. Whole‐body protein lurnover before and after resection of colorectal tumours
93. Skeletal muscle metabolism in palients with malignant tumours
94. Efflux of 3 methylhislidine from Ihe leg in cancer palients who experience weight loss
95. Tissue components of weight loss in cancer patienls: a new method of study and preliminary observalions
96. 131I albumin degradalion in palients with neoplastic diseases
97. Albumin metabolism in patients with lymphoma
98. Intravenous hyperalimentation in cancer patients
99. Total parenteral nutrition in the cancer patient
100. Effects of total parenteral nutrition on tumour‐host responses in rats
101. The effects of glucose and amino acids on tumour and host DNA synthesis
102. Refeeding differentially affects tumour and host cell proliferation
103. Intravenous hyperalimentation as nutritional support for the cancer patient; an update
104. Protein synthesis dynamics in human gastrointestinal malignancies
105. Aspects of amino acid and protein metabolism in cancer‐bearing states
106. Macronutrient requirements in the malnourished cancer patient. How much of what and why?
107. Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight
108. Host tumour interaction and nutrient supply
109. Comparison of intravenous glucose and fat calories on host and tumour growth
110. Protein sparing effect of substrate infusion in surgical patients is governed by the clinical state, and not by the individual substrate infused
111. Abnormal hyperalimentation response in cachectic cancer patients
112. Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia
113. Influence of stress, depletion, and/or malignant disease on the responsiveness of surgical patients to total parenteral nutrition
114. Branched‐chain amino acid solutions enhance N accretion in postoperative cancer patients
115. Cancer and protein metabolism
116. Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia
117. The effects of perioperative hyperalimentation on complications in patients with cancer and weight loss
118. Parenteral nutrition in carcinoma of the oesophagus treated by surgery: nitrogen balance and clinical studies
119. Perioperative parenteral nutrition: a meta‐analysis
120. Preoperative intravenous feeding: a controlled clinical trial
121. Preoperative parenteral feeding in patients with gastrointestinal carcinoma
122. Influence of hydrazine sulphate on food intake and weight maintenance in patients with cancer
123. High dose megestrol acetate: a possible treatment for cachexia
124. Cachexia of malignancy: potential role of insulin in nutritional management
125. Insulin reverses anorexia and biochemical changes in tumour‐bearing rats
126. Insulin reversal of cancer cachexia in rats
127. Insulin and acivicin improve host nutrition and prevent tumour growth during total parenteral nutrition
128. Energy and nitrogen metabolism in cancer
129. Control of food intake in cancer cachexia: a challenge and a tool
130. Toxohormone
131. Paraneoplastic syndromes in experimental animal model systems
132. Metabolic response to sepsis and trauma
133. Passive immunization against cachectin/tumour necrosis factor protects mice from lethal effects of endotoxin
134. Identity of tumour necrosis factor and the macrophage secreted factor cachectin
135. Cachectin: more than a tumour necrosis factor
136. Chronic TNF infusion causes anorexia but not accelerated nitrogen loss
137. An integrated analysis of glucose, fat and protein metabolism in severely traumatized patients: studies in the basal state and the response to intravenous nutrition
138. Determination of glucose turnover and oxidation in normal volunteers and septic patients using stable and radio isotopes: the response to glucose infusion and total parenteral nutrition
139. Mechanisms of insulin resistance following injury
140. Substrate turnover after injury
141. Starvation in man
142. The effect of sepsis on the oxidation of carbohydrate and fat
143. 14C]leucine
144. Energy balance and carbohydrate metabolism in infection and sepsis